SCHEMBL21116488

SCHEMBL21116488

FC(F)(F)c1ccc(-c2ccc(C(F)(F)F)c(-n3c4cc(-n5c6ccccc6c6ccccc65)ccc4c4ccc(-n5c6ccccc6c6ccccc65)cc43)c2)cc1-n1c2cc(-n3c4ccccc4c4ccccc43)ccc2c2ccc(-n3c4ccccc4c4ccccc43)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
KIF11 P52732 3/20 0.37
ALDH1A1 P00352 2/20 0.33
AR P10275 3/20 0.32
RORC P51449 1/20 0.32
HDAC4 P56524 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
NR3C1 P04150 1/20 0.31
PGR P06401 1/20 0.31
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
EDNRB P24530 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21116288 1.00 L3MBTL1 (0.40) L3MBTL1KDM4EATMKIF11ALDH1A1
SCHEMBL21116489 0.91 L3MBTL1 (0.40) L3MBTL1KDM4EATMKIF11ALDH1A1
SCHEMBL21116492 0.91 L3MBTL1 (0.40) L3MBTL1KDM4EATMKIF11ALDH1A1
SCHEMBL21116557 0.89 L3MBTL1 (0.40) L3MBTL1KDM4EATMKIF11ALDH1A1
SCHEMBL21116535 0.87 KIF11 (0.52) L3MBTL1KDM4EATMKIF11PPARG
SCHEMBL21116516 0.86 KIF11 (0.38) L3MBTL1KDM4EATMKIF11ALDH1A1
SCHEMBL21116538 0.86 KIF11 (0.44) L3MBTL1KDM4EATMKIF11PPARG
SCHEMBL21116341 0.85 SCN9A (0.43) ALDH1A1ARNR3C1PGR
SCHEMBL21116556 0.84 LDHA (0.42) L3MBTL1KIF11ALDH1A1CYP11B2HSD17B1
SCHEMBL21132055 0.84 KDM4E (0.43) L3MBTL1KDM4EATMKIF11AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136294-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-10-05 US disclosed
EP-3478656-B1 DICARBAZOLE DIPHENYL DERIVATIVES FOR USE IN OPTOPELECTRONIC DEVICES CYNORA GMBH (DE) 2021-09-08 EP disclosed
US-20190194130-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194130-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, NOX3, ORC3 L3MBTL1 2678/4885KDM4E 1656/4885ATM 4063/4885
US-11136294-B2 Organic molecules for use in optoelectronic devices OR10J3, ORC3, NOX3 L3MBTL1 2423/4885KDM4E 1959/4885ATM 3947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.